You are here

Amgen

Amgen and Genentech are the latest drug makers to lay off workers

Stat

Sat, 11/4/17 - 07:23 pm

drug manufacturing

Novartis and Amgen launch new Alzheimer’s study

Endpoints

Thu, 11/2/17 - 10:12 pm

Alzheimer's disease

clinical trials

Amgen buries the last big CETP drug, marking the bitter end of a blockbuster quest

Endpoints

Fri, 10/27/17 - 11:12 am

drug development

CETP inhibitors

Amgen faces conundrum as biosimilars both help and hurt

BioPharma Dive

Fri, 10/27/17 - 11:00 am

drug manufacturing

What's Behind Amgen's Q3 Revenue Decline

Motley Fool

Thu, 10/26/17 - 09:22 am

What’s driving the rapid growth of the top 20 biopharma companies in the world?

Endpoints

Wed, 10/25/17 - 11:24 am

What's next for biopharma Q3 earnings

Biopharma Dive

Sat, 10/21/17 - 09:50 pm

Bristol-Myers Squibb

Gilead Sciences

[forum discussion]New neuro sales force for Amgen migraine drug erenumab

Cafepharma Message Boards

Tue, 10/17/17 - 12:40 pm

Regeneron-Sanofi food allergy drug succeeds mid-stage study

Yahoo/Reuters

Mon, 10/16/17 - 09:50 am

eosinophilic esophagitis

Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL

Fierce Pharma

Tue, 10/10/17 - 10:18 am

PCSK9 court saga drags on for Sanofi, Regeneron and Amgen

Biopharma Dive

Mon, 10/9/17 - 09:36 am

PCSK9 inhibitors

Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen

Fierce Pharma

Thu, 10/5/17 - 09:34 am

Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer

Endpoints

Wed, 10/4/17 - 11:23 am

Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B

RAPS.org

Mon, 10/2/17 - 11:18 am

How Good Is AbbVie's Humira Deal With Amgen?

Motley Fool

Fri, 09/29/17 - 10:06 am

Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023

Marketwatch

Thu, 09/28/17 - 09:50 am

Amgen targets China in cancer biosimilar development deal with Simcere

Fierce Pharma

Thu, 09/28/17 - 09:43 am

drug development

Amgen reaffirms 2017 guidance in wake of Hurricane Maria

Marketwatch

Mon, 09/25/17 - 09:56 am

drug manufacturing

Pharma executives wary of value-based deals, but see the potential benefits: PwC

Fierce Pharma

Fri, 09/22/17 - 11:13 am

value-based contracts

Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients

Fierce Pharma

Mon, 09/18/17 - 11:08 am

PCSK9 inhibitors

Pages